237 related articles for article (PubMed ID: 7537117)
41. Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells.
Lagneaux L; Delforge A; Snoeck R; Stryckmans P; Bron D
Exp Hematol; 1994 Jan; 22(1):26-30. PubMed ID: 7506672
[TBL] [Abstract][Full Text] [Related]
42. Production of granulocyte colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor after interleukin-1 stimulation of marrow stromal cell cultures from normal or aplastic anemia donors.
Migliaccio AR; Migliaccio G; Adamson JW; Torok-Storb B
J Cell Physiol; 1992 Jul; 152(1):199-206. PubMed ID: 1377699
[TBL] [Abstract][Full Text] [Related]
43. Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group.
Pelliniemi TT; Irjala K; Mattila K; Pulkki K; Rajamäki A; Tienhaara A; Laakso M; Lahtinen R
Blood; 1995 Feb; 85(3):765-71. PubMed ID: 7530507
[TBL] [Abstract][Full Text] [Related]
44. [Role of cytogenetics in the prognosis of patients with multiple myeloma].
Paluszewska M; Dwilewicz-Trojaczek J; Stańczak H; Brycz-Witkowska J; Chmarzyńska-Mróz E; Rokicka M; Torosian T; Wasiutyński A; Jedrzejczak WW
Pol Arch Med Wewn; 2003 Sep; 110(3):973-9. PubMed ID: 14699690
[TBL] [Abstract][Full Text] [Related]
45. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium.
De Bruyn C; Delforge A; Bron D; Ley P; de Hemptinne D; Stryckmans P
Stem Cells; 1994 Nov; 12(6):616-25. PubMed ID: 7533580
[TBL] [Abstract][Full Text] [Related]
46. A new staging system for multiple myeloma based on the number of S-phase plasma cells.
San Miguel JF; García-Sanz R; González M; Moro MJ; Hernández JM; Ortega F; Borrego D; Carnero M; Casanova F; Jiménez R
Blood; 1995 Jan; 85(2):448-55. PubMed ID: 7811998
[TBL] [Abstract][Full Text] [Related]
47. Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture.
Coutinho LH; Will A; Radford J; Schiró R; Testa NG; Dexter TM
Blood; 1990 Jun; 75(11):2118-29. PubMed ID: 1693295
[TBL] [Abstract][Full Text] [Related]
48. Cytogenetic studies of non-lymphocytic neoplasias using hematopoietic growth factors: GM-CSF provides pronounced mitotic increase and improvement of the quality of banded chromosomes compared to G-CSF.
Nakamura H; Sasagawa I; Itoyama T; Mine M; Amenomori T; Sadamori N; Tomonaga M
Leukemia; 1993 Sep; 7(9):1471-5. PubMed ID: 7690442
[TBL] [Abstract][Full Text] [Related]
49. Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia.
Briggs M; Adams JA; Brereton ML; Burgess R; Hyde K; Lenehan H; Yin JA
Br J Haematol; 2001 Dec; 115(3):563-8. PubMed ID: 11736936
[TBL] [Abstract][Full Text] [Related]
50. Multifactor stimulation of megakaryocytopoiesis: effects of interleukin 6.
Quesenberry PJ; McGrath HE; Williams ME; Robinson BE; Deacon DH; Clark S; Urdal D; McNiece IK
Exp Hematol; 1991 Jan; 19(1):35-41. PubMed ID: 1703492
[TBL] [Abstract][Full Text] [Related]
51. Granulocyte colony-stimulating factor (CSF) but not interleukin-1 (IL-1), IL-3, and granulocyte-macrophage CSF protect bone marrow progenitor cells from suppression by allosensitized cytotoxic T cells.
Gerritsen WR; O'Reilly RJ
Blood; 1994 Sep; 84(6):1906-12. PubMed ID: 7521693
[TBL] [Abstract][Full Text] [Related]
52. Establishment and characterization of a new granulocyte-macrophage colony-stimulating factor-dependent and interleukin-3-dependent human acute myeloid leukemia cell line (GF-D8).
Rambaldi A; Bettoni S; Tosi S; Giudici G; Schirò R; Borleri GM; Abbate M; Chiaffarino F; Colotta F; Barbui T
Blood; 1993 Mar; 81(5):1376-83. PubMed ID: 8443395
[TBL] [Abstract][Full Text] [Related]
53. Effect of interleukin-4 on the growth of granulocyte-macrophage progenitor cells stimulated by hematopoietic growth factors.
Sato T; Misago M; Tsukada J; Kikuchi M; Oda S; Chiba S; Eto S
J UOEH; 1990 Jun; 12(2):163-74. PubMed ID: 1697091
[TBL] [Abstract][Full Text] [Related]
54. Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial.
Nemec P; Zemanova Z; Kuglik P; Michalova K; Tajtlova J; Kaisarova P; Oltova A; Filkova H; Holzerova M; Balcarkova J; Jarosova M; Rabasova J; Hruba M; Spicka I; Gregora E; Adam Z; Scudla V; Maisnar V; Schutzova M; Hajek R;
Leuk Lymphoma; 2012 May; 53(5):920-7. PubMed ID: 22023516
[TBL] [Abstract][Full Text] [Related]
55. Action of interleukin-3, G-CSF, and GM-CSF on highly enriched human hematopoietic progenitor cells: synergistic interaction of GM-CSF plus G-CSF.
McNiece I; Andrews R; Stewart M; Clark S; Boone T; Quesenberry P
Blood; 1989 Jul; 74(1):110-4. PubMed ID: 2473792
[TBL] [Abstract][Full Text] [Related]
56. Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation.
Nilsson T; Lenhoff S; Turesson I; Rylander L; Mitelman F; Westin J; Höglund M; Johansson B
Eur J Haematol; 2002 Jun; 68(6):345-53. PubMed ID: 12225392
[TBL] [Abstract][Full Text] [Related]
57. [The cytogenetic and molecular genetic study of 81 multiple myeloma patients].
Li JT; Chang NB; Liu H; Pei L
Zhonghua Nei Ke Za Zhi; 2011 Dec; 50(12):1039-42. PubMed ID: 22333174
[TBL] [Abstract][Full Text] [Related]
58. An abnormal nonhyperdiploid karyotype is a significant adverse prognostic factor for multiple myeloma in the bortezomib era.
Tan D; Teoh G; Lau LC; Lim A; Lim TH; Yap KC; Premalatha P; Lao ZT; Wee N; Choo C; Wee HC; Su S; Lee YS; Lee LH; Hwang W; Goh YT
Am J Hematol; 2010 Oct; 85(10):752-6. PubMed ID: 20721886
[TBL] [Abstract][Full Text] [Related]
59. Response of myelodysplastic syndrome marrow progenitor cells to stimualtion with cytokine combinations in a stroma-free long-term culture system.
Soligo DA; Campiglio S; Servida F; Bossolasco P; Romitti L; Cortelezzi A; Lambertenghi Deliliers G
Br J Haematol; 1996 Mar; 92(3):548-58. PubMed ID: 8616015
[TBL] [Abstract][Full Text] [Related]
60. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
